Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC

Clinical trial NCT02591615 · COMPLETED

Trial details

NCT number: NCT02591615
Sponsor: Alliance Foundation Trials, LLC.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer

Start date: 2016-03-01
Primary completion: 2019-01-04
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.